The FDA issued a warning in June 2026 calling compounded versions "potentially risky for patients." Despite that warning, compounded GLP-1 products remain in use, partly because they cost significantly less than brand-name alternatives
The $2,000 Out-of-Pocket Cap Changes the Math The Inflation Reduction Act (IRA) restructured Medicare Part D cost-sharing beginning January 1, 2025
It targets two hormone receptors, GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)
Our team of experienced physicians and nurse practitioners are dedicated to helping you reach your goals in a safe and effective way
Bessesen said if patients experience bad side effects, lose weight too rapidly or see good progress on a lower dose, they can talk to their doctors about staying on a lower dose longer
Butyrate binds to the L-cell receptors that triggers GLP-1 release